Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
Clinical trial NCT01757535 · COMPLETED
Trial details
- NCT number
- NCT01757535
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-24
- Primary completion
- 2019-07-15
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.